ABSTRACT. We assessed the change of bone mineral density (BMD) in lactating beagles with dual energy X-ray absorptiometry (DXA) and the preventive effect of 1α-hydroxyvitamin D3 (1α(OH)D3) on the BMD. Beagles, two to five years old, were used for detecting the time course change of BMD. Since the coefficient of variation (CV(%)) on detecting lumber vertebral (L2-L4) and tibial BMD by DXA was about 0.5%, DXA was useful to detect the change of BMD in beagles. There was a marked decrease in vertebral BMD during lactational period in the control group. The BMD levels after weaning were found to reverse to the initial level at mating. The same tendency was observed in tibial BMD as vertebral BMD, though the BMD changes were not marked. Beagles were administered at a dose of 0.1 µg/kg of 1α(OH)D3 three times in a week, and it was found to suppress the decrease in vertebral BMD during the breast feeding period. Also, the administration of 1α(OH)D3 promoted the prevention of decreased BMD during lactation both in vertebrae and tibiae. Significant effects of 1α(OH)D3 administration on tibial BMD were not observed. No adverse effects, such as hypercalcemia and hypercalciuria, were observed during the experimental period. Therefore, DXA was useful for detecting the changes of BMD in lactating beagles and the change of BMD was marked in lumber vertebrae, which are rich in trabecular bone. The preventive effect of 1α(OH)D3 on the decrease of BMD during the lactation period was observed in beagles. study, and were kept in individual cages. Room temperature was preserved at between 15°C and 22°C, relative humidity was 45-70%, a ventilation system was employed and natural light was provided. The beagles were kept on normal chow containing 1.2% calcium and 0.9% phosphate (CD-5, Clea Japan Inc.). The amount of food fed to each beagle varied from 250 g to 500 g during the reproduction cycle, 250 g in estrus, 375 g in pregnancy, 500 g in lactation and 250 g after weaning. Drinking water was given ad libitum. The pups were supplemented soaked CD-5 in water plus to the mother's breast milk in the fourth week postpartum. Breast feeding was stopped at five-week after delivery. Administration and schedule: Seven beagles were divided into two groups, three dogs were administered 1α(OH)D3 (Chugai Pharm. Co., Ltd.) at a dose of 0.1 µg/kg and the control group was given vehicle. Medium chain triglyceride was used as vehicle and 1α(OH)D3 was adjusted to a concentration of 0.5 µg/ml with the vehicle. Administration volume was at a dosage of 0.2 ml/kg, and was administered by using an oral catheter. Dogs were administered the compound three times in a week for 14 weeks, from 2 weeks before delivery until 12 weeks postpartum.
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Coefficient of variation of bone mineral density by DXA: Using a model of DCS-3000 (Aloka Co., Ltd.), lumber vertebral (L2-L4) and tibial bone mineral density (BMD) in beagles were measured under pentobarbital anesthesia. The vertebral BMD was measured in the supine position and tibial BMD was in lateral position. The X-ray applied from the belly side on measurement of vertebral BMD and from left side on that of tibial BMD. Two beagles were selected to determine the coefficient of variation (CV(%)=standard deviation/mean × 100) on BMD by DXA, one had a Maternal calcium demand during lactation is highly increased for the supply of breast milk. This excess calcium demand requires the increment of bone resorption, intestinal calcium absorption, and/or calcium resorption in kidney. These adaptations, however, were observed species dependently. The increment of intestinal calcium absorption as well as bone resorption [7, 9] , based on elevation of parathyroid hormone (PTH) and 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3), were reported in rats [2, 3, 7, 22] . While in human, calcium resorption in kidney and skeletal calcium mobilization were elevated without up-regulation of PTH and 1α,25(OH)2D3 [5, 14, 21, 23] .
Skeletal change during the lactational period has been precisely documented in rodents. Lactating rats were found to have lost bone mineral, as determined by a variety of methods [7, 10, 18, 27] . The bone loss could be increased by consumption of a low calcium diet starting at delivery [7, 19, 24] . Rats, which are short-lived animals, have large litter sizes and the bone change during lactation would be substantial. This bone change during lactation is accompanied by the increment of bone turn over [6, 16] .
Therefore, we used beagles as long-lived mammals, and estimated the impact of lactation on the time course change of bone loss with dual energy X-ray absorptiometry (DXA). Also, we examined the preventive effect of 1α-hydroxyvitamin D3 (1α(OH)D3), a therapeutic agent for osteoporosis in Japan, on bone loss in lactation in beagles, which have remodeling in bone [13] .
MATERIALS AND METHODS

Animals:
Seven beagles, 2-5 years old, were used in this FULL PAPER Laboratory Animal Science maximum weight and another had a minimum weight in this experiment. Measurement was performed five times to obtain the CV(%) of BMD by DXA on both vertebrae and tibiae.
Measurement of bone mineral density by DXA: All data are the average of the two measurements of BMD. Measurements were performed at mating as initial values, at delivery and in every two weeks after delivery.
Urine and serum sampling: Blood was collected from intermediate antebrachial vein. The blood was centrifuged and serum was obtained. Urine was collected using a catheter from bladder under ketamine anesthesia. Each sample was obtained at 24 hr after the administration. These samplings were undertaken at mating, delivery and in 2 weeks intervals following delivery.
Serum and urinary parameter assessment: Serum and urinary calcium were assayed by OCPC method with calcium C-test kit (Wako Pure Chemicals Industries, Ltd.). Serum alkaline phosphatase (ALP) was measured by GSCC method with ALP kit (Iatron). Tartrate resistant acid phosphatase (TRACP) was determined by Bessey-Lowry method with ACP kit (Nittobo Co.,Ltd.). Urinary creatinine was measured by colorimetric method with creatinine kit (Iatron).
Statistical analysis: Analysis of the number of neonates was performed by Student's t-test. Statistical significance on longitudinal data of BMD was analyzed by mixed model with group, time and group-time interaction as fixed, subject as random effect. P-values of less than 0.05 were defined as significant.
RESULTS
All beagles were found to suffer from a loss of appetite throughout the pregnancy and post-partum. The number of neonates was not statistically different between experimental groups. Means and standard deviations (SD) of the number were 7.3 ± 1.3 in the control and 6.3 ± 0.48 in the 1α(OH)D3 group. Mean, SD and CV(%) of vertebral and tibial BMD were shown in Table 1 . From these results, we concluded that a time course change of vertebral BMD and tibial BMD could be detected by DXA. Figure 1 shows the BMD changes in vertebrae in percentage, BMD at mating sets as 100%. It was found that vertebral BMD was at a minimum at 4 weeks after delivery in the two groups. The BMD in the control group and the 1α(OH)D3 treatment group were reduced to 24% and 12%, respectively. Vertebral BMD in both control and 1α(OH)D3 groups recovered by 95% and 103%, respectively, after weaning. Treatment of 1α(OH)D3 prevented the decrease of BMD in lactation and significantly induced the recovery of the reduced BMD after weaning.
Time course changes of tibial BMD are shown in Fig. 2 . The BMD were also reduced during lactation but the degrees in tibial BMD were smaller than that of the vertebrae. Maximum reduction of the BMD was 8% at 4 weeks in the control and 5% at 6 weeks in the 1α(OH)D3 group. Figure 3 shows the results of serum and urinary biochemical parameters. Alkaline phosphatase (ALP) levels in both the control group and the 1α(OH)D3 treated group increased in the breast-feeding period, and these levels returned to the initial levels at mating after weaning in both groups (Fig. 3-A) . Tartrate-resistance acid phosphatase (TRACP) levels were unchanged during lactational period and by the treatment of 1α(OH)D3 (Fig.3-B) . Hypercalcemia ( Fig. 3-C) and hypercalciuria ( Fig. 3-D) were not induced by the treatment of 1α(OH)D3.
DISCUSSION
Time course changes in vertebral and tibial BMD in maternal beagles from lactation to weaning periods could be detected by DXA. Beagles lost their vertebral BMD as much as 24% compared to the initial level at mating during the 4 weeks breast feeding period, since calcium must be mobilized into the breast milk. These beagles took about 5 g of calcium in a day during the lactation period from diet. Although, the efficiency of intestinal calcium absorption is unknown, the total amount of calcium intake appears to be sufficient for beagles in lactation. We observed biochemical bone markers, ALP as bone formation parameter and TRACP as bone resorption parameter. Elevated ALP activities suggested the induction of bone formation during lactation period, while TRACP activities were not found the increment based on lactation. TRACP might be unsuitable for observing bone turn over in lactation. Since treatment of 1α(OH)D3 had no effect on ALP activities, the bone formation might not be affected by administration of 1α(OH)D3. In clinical study, bone resorption was inhibited by the treatment of 1α,25(OH)2D3 [1] . On bone formation, ALP and bone gla-protein are upregulated by in in vitro [15, 18] , but the effect of 1α,25(OH)2D3 in in vivo is still unclear.
Administration of 1α(OH)D3 at a dose of 0.1 µg/kg might be adequate dose in lactating beagles, because the preventive effect on BMD was observed without adverse effects. Daily administration of 1α(OH)D3 at a dose of 0.1 µg/kg for 10 weeks induced hypercalcemia in beagles in safety assessment study (unpublished data). Administration of 1α(OH)D3 three times in a week at the same dose for 14 weeks was seemed to be enough dose to make the calcium balance in the beagles positive.
Factors related to the reduction of bone mineral in lactation are still unknown. Parathyroidectomy or vitamin D deficient rats were used to make the mechanism of the lactational bone loss clear, but PTH and vitamin D were reported not to relate the bone loss [9, 11] . One of the candidates for this bone loss is thought to be parathyroid hormone related peptide (PTHrP). PTHrP is produced extremely in the mammary glands during lactation and PTHrP in maternal blood was found to be higher level than normal [4, 8] . Bone resorption is induced by PTHrP as well as PTH [20] , therefore, the bone loss in lactation may be induced by PTHrP. 1α(OH)D3 is believed to be converted into 1α,25(OH)2D3 before revealing the biological function in in vivo. Therefore, serum 1α,25(OH)2D3 level in 1α(OH)D3 treatment group would be elevated. The elevated 1α,25(OH)2D3 might suppress PTHrP production in lactation, since PTHrP is negatively regulated by 1α,25(OH)2D3 [12] , although, this remains to be established.
A greater difference was observed on the decrease of vertebral BMD than on tibial BMD. The vertebrae are rich in trabecular bone, and bone resorption would have mainly occurred in trabecular bone rather than in cortical bone in the period of breast-feeding [6, 16] . Otherwise, weight load would be one of the related factor on bone loss, tibiae would be under more weight load than that in vertebrae in beagles because of pronograde.
From our experiment, we observed that lactation induced bone loss in beagles, long-lived mammals, as well as rats. Further, 1α(OH)D3 prevented bone loss in lactation and induced recovery of decreased bone minerals after weaning.
